Sophont

Tanishq Mathew Abraham, Ph.D. Verified account @iScienceLuvr · Oct 20

Cancer patients with the same diagnosis often have very different tumor biology.

Molecular testing can reveal underlying differences, but that's slow and expensive.

Introducing Holon-S1, our platform to predict genes and biomarkers from routine pathology slides.

• beats two other models at predicting spatial gene activity in a controlled comparison
• has identified potentially novel biomarkers in breast cancer and colon cancer
• evaluated across 16 organ types and more than 15 scanners, using slides from both formalin-fixed, paraffin-embedded and fresh-frozen tissue.

We believe Holon-S1 has the potential to help researchers find new biomarkers in slides they already have, discover treatment targets, and bring more personalized cancer care within reach!

View quoted post on X

MTS @MTSlive · Oct 20

DEEPSEEK INFERENCE | CHINA LABS BUY NVIDIA CHIPS | ANTHROPIC X CITRINI x.com/i/broadcasts/1…

View quoted post on X

Tanishq Mathew Abraham, Ph.D. Verified account @iScienceLuvr · Aug 14

At @SophontAI, the plan is simple:
1. build encoders for every single modality in medicine and biology
2. align the latent spaces of all the encoders into a unified patient representation
3. use the unified patient representation to diagnose and treat patients
3. PROFIT

View quoted post on X